United States · FDA National Drug Code directory
VASOPRESSIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51662-1623_39ae8951-80f9-e2c7-e063-6294a90a4f43
- Product NDC
- 51662-1623
- Form
- INJECTION
- Composition / generic term
- VASOPRESSIN
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230302
- Source listing expiry
- 20261231
Source-listed ingredients
- VASOPRESSIN, UNSPECIFIED — 20 [USP'U]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 mL in 1 VIAL, MULTI-DOSE (51662-1623-1) · 51662-1623-1
- 1 VIAL, MULTI-DOSE in 1 POUCH (51662-1623-2) / 1 mL in 1 VIAL, MULTI-DOSE · 51662-1623-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →